Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

STEM vs GERN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GERN Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 10–0 Matrix Metrics)

GERN Overall Winner 6-Pillar Tally: STEM 1 – 5 GERN Matrix Metrics: STEM 0 – 10 GERN

As of Nov 20, 2026, Geron Corp (GERN) is the stronger overall head-to-head candidate over Stem, Inc. (STEM) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STEM carries a Unified Composite Score of 42.4/100 (HOLD) at $0.64 (N/M Forward P/E, -12.1% operating margin), whereas GERN carries 48.4/100 (HOLD) at $0.87 (49.5x Forward P/E, -7.2% operating margin).

  • Technical & Structure Timing Caution: STEM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.9); meanwhile GERN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About STEM vs GERN
STEM NYSE
Stem, Inc.
Miscellaneous Electrical Machinery, Equipment & Supplies
$0.64
-12.73% 1D
Market Cap $7.1M
TTM Revenue $146M
Forward P/E N/M
Beta / 30D Vol 4.60β · 234% Vol
Unified Composite Score
42.4 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 61.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.5%), weak momentum, RSI 23
RSI-14: 22.9 · SMA20: $2.13 · SMA50: $3.30
GERN NASDAQ Head-to-Head Winner
Geron Corp
Pharmaceutical Preparations
$0.87
-4.63% 1D
Market Cap $588.2M
TTM Revenue $218M
Forward P/E 49.5x
Beta / 30D Vol 1.48β · 102% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 65.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.6%), weak momentum, RSI 35
RSI-14: 35.3 · SMA20: $0.98 · SMA50: $1.13

6-Pillar Scorecard Institutional Category Breakdown (STEM 1 – 5 GERN)

Columns: Metric · STEM · GERN
1. Valuation Multiples GERN
Forward P/E N/M 49.5x
Trailing P/E N/M 49.5x
PEG Ratio N/M N/M
EV / Revenue N/M 2.9x
2. Growth & Scale GERN
Revenue Growth (YoY) -4.1% +27.4%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $146M $218M
Market Cap $7.1M $588.2M
3. Profitability & Quality GERN
Gross Margin 47.6% 62.5%
Operating Margin -12.1% -7.2%
Net Profit Margin -43.6% -22.0%
Return on Equity (ROE) -5920.8% -20.1%
4. Balance Sheet & Cash Flow STEM
Cash Generation (TTM) $7.1M -$91M
Cash Flow Margin 4.9% -41.9%
Net Cash / Leverage -5920.8% ROE $52M Net Debt (0.53x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning GERN
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 175.8% (39th %ile) 103.2% (19th %ile)
Put/Call OI Skew 0.14x (Call-Skewed) 0.15x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat GERN
OpEx & R&D Intensity 59.7% of Rev ($87M) 69.7% of Rev ($152M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Utilities - Renewable Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: STEM (0) vs GERN (10)
Institutional Metric STEM GERN Criterion Row Edge
Market Capitalization
Scale
$7.1M $588.2M Larger Scale GERN
Trailing P/E Ratio
Valuation
N/M 49.5x Lower Multiple GERN
Forward P/E Ratio
Valuation
N/M 49.5x Lower Multiple GERN
Revenue Growth (YoY)
Growth
-4.1% +27.4% Higher Growth GERN
Operating Margin (TTM)
Profitability
-12.1% -7.2% Higher Margin GERN
Net Profit Margin
Profitability
-43.6% -22.0% Higher Margin GERN
Return on Equity (ROE)
Capital Efficiency
-5920.8% -20.1% Higher ROE GERN
52-Week Range Position
Momentum
0% ($1–$22) 3% ($1–$2) Stronger Trend GERN
Beta / 30D Volatility
Risk Regime
4.60β · 234% Vol 1.48β · 102% Vol Lower Realized Risk GERN
Unified Institutional Score
Composite Signal
42.4 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite GERN
Trailing 12M Revenue (USD)
Operating Scale
$146M $218M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.6% 62.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 2.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.1M (-5920.8% ROE) -$91M ($52M Net Debt (0.53x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GERN +55.82 pp
STEM: -78.77% · GERN: -22.95%
3M Horizon GERN +45.54 pp
STEM: -88.26% · GERN: -42.72%
6M Horizon GERN +61.24 pp
STEM: -93.22% · GERN: -31.98%
1Y Horizon GERN +76.46 pp
STEM: -95.84% · GERN: -19.38%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period STEM Revenue GERN Revenue STEM Op. Margin GERN Op. Margin Margin Leader
FY2018 N/A $0M N/A -2914.9% GERN
FY2019 $20M $0M -272.6% -15762.0% STEM
FY2020 $40M $0M -136.0% -30400.4% STEM
FY2021 $130M $0M -65.2% -8183.7% STEM
FY2022 $360M $0M -36.1% -23246.6% STEM
FY2023 $460M $0M -38.9% -81832.9% STEM
FY2024 $140M N/A -580.6% N/A STEM
FY2025 $160M N/A -35.6% N/A STEM

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
STEM BREAKDOWN
145d in phase · OBV DISTRIBUTION
Current IV 175.8%
IV Percentile 39th %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact STEM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GERN BREAKDOWN
76d in phase · OBV DISTRIBUTION
Current IV 103.2%
IV Percentile 19th %ile
Put/Call OI Skew 0.15x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact GERN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
STEM Moat Profile Cyclical / Execution-Driven Positioning
Utilities - Renewable Operator
Competes within the Utilities - Renewable value chain with $7.1M market capitalization and -12.1% operating margin.
OpEx & R&D Reinvestment 59.7% of Rev ($87M)
90D Engineering Disclosures 0 Published
GERN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $588.2M market capitalization and -7.2% operating margin.
OpEx & R&D Reinvestment 69.7% of Rev ($152M)
90D Engineering Disclosures 0 Published

Investor FAQ STEM vs GERN Key Questions & Quantitative Answers

As of Nov 20, 2026, Geron Corp (GERN) is the stronger overall head-to-head candidate over Stem, Inc. (STEM) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STEM carries a Unified Composite Score of 42.4/100 (HOLD) at $0.64 (N/M Forward P/E, -12.1% operating margin), whereas GERN carries 48.4/100 (HOLD) at $0.87 (49.5x Forward P/E, -7.2% operating margin). Technical & Structure Timing Caution: STEM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.9); meanwhile GERN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GERN leads the Growth & Scale pillar: STEM posts -4.1% YoY revenue growth and +0.0% YoY earnings growth on $146M TTM revenue (47.6% gross margin, -12.1% operating margin), compared with GERN at +27.4% YoY revenue growth and +0.0% YoY earnings growth on $218M TTM revenue (62.5% gross margin, -7.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), STEM cumulative revenue shifted +700.0% while GERN shifted N/A. In operating R&D and SG&A reinvestment, STEM deploys 59.7% of Rev ($87M) (0 90-day corporate R&D disclosures) versus 69.7% of Rev ($152M) (0 disclosures) for GERN.

GERN screens cheaper on headline valuation multiples. STEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (4.9% FCF margin), whereas GERN trades at 49.5x Forward P/E, 49.5x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (-41.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against STEM (-5920.8% ROE) versus GERN (-20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, STEM carries 175.8% implied volatility (39th %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (4.60β · 234% Vol realized risk). By comparison, GERN carries 103.2% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.15x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.48β · 102% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.